Research Frontiers Incorporated
REFR · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | 0.43 | 0.05 | -1.40 |
| FCF Yield | -0.14% | -1.69% | 0.08% | -0.35% |
| EV / EBITDA | -72.84 | -196.29 | -120.17 | -379.58 |
| Quality | ||||
| ROIC | -26.90% | -6.49% | -16.01% | -7.90% |
| Gross Margin | 64.00% | 100.00% | 23.24% | 88.04% |
| Cash Conversion Ratio | 0.48 | 0.10 | 3.61 | -0.08 |
| Growth | ||||
| Revenue 3-Year CAGR | 19.06% | 19.65% | 37.09% | 35.26% |
| Free Cash Flow Growth | 87.76% | -1,488.30% | 117.87% | -38.28% |
| Safety | ||||
| Net Debt / EBITDA | 0.06 | 0.46 | 1.48 | 8.12 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 324.74 | 129.96 | 276.04 | 193.27 |